← Back to Patent Explorer
US3758682A Expired / Lapsed US ⏱️ 0.0 years remaining

Pharmaceutical compositions comprising orgotein and their use

Assignee: DIAGNOSTICS DATA Inc
•
Filing: 1972-03-23
•
Granted: 1973-09-11
•
Expires: 1992-03-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Pharmaceutical compositions comprising, in a pharmaceutically acceptable carrier, an effective unit dosage amount of orgotein, the non-proprietary name assigned to members of a family of globular, soluble metalloprotein congeners whose compact conformation is maintained by chelated divalent metals, usually about 2 GAPM each of Cu and Zn, in isolated, substantially pure or pure form, some of which metalloproteins, in various states of purity, have been named erythrocuprein, hepatocuprien, cerebrocuprien, cytocuprein and superoxide dismutase, are useful in the treatment of inflammatory, shock and toxic conditions.

Inventors

  • 👤 W Huber
  • 👤 T Schulte

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 13:40
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/0004; C12N9/0089; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S530/00; Y10S530/806; Y10S530/827; Y10S530/829; Y10S530/843; Y10S530/846

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 11 words
A pharmaceutical composition according to claim 1 adapted for parenteral administration.
Claim 2
Dependent Claim 11 words
A pharmaceutical composition according to claim 2 adapted for intramuscular administration.
Claim 3
Dependent Claim 15 words
A pharmaceutical composition according to claim 1 wherein the orgotein is free from proteinaceous impurities.
Claim 4
Dependent Claim 12 words
A pharmaceutical composition according to claim 1 as a sterile, aqueous solution.
Claim 5
Dependent Claim 22 words
A pharmaceutical composition according to claim 5 wherein the solution contains 0.5 to 20 mg. of orgotein per 0.25 to 10 ml.
Claim 6
Dependent Claim 12 words
A pharmaceutical composition according to claim 5 wherein the solution is isotonic.
Claim 7
Dependent Claim 11 words
A pharmaceutical composition according to claim 1 adapted for topical administration.
Claim 8
Dependent Claim 16 words
A pharmaceutical composition according to claim 8 wherein the carrier is viscous liquid, semi-solid or solid.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1976-09-10 1977-03-12 1977-09-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1980-09-10 1981-03-12 1981-09-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1984-09-10 1985-03-12 1985-09-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag